As the cannabis industry continues its steady growth, one public exchange in Canada has seen a momentum increase in its stocks thanks to favorable policy in the US.
Barrington Miller, director of listed company services for the Canadian Securities Exchange (CSE) credited the approach by the exchange to allow the listing of non licensed producer (LP) cannabis ventures early on the rush for these stocks, he told the Investing News Network (INN).
On Monday (May 28) the exchange hosted a conversation with investors on the cannabis listed companies offering exposure into various markets across the US and Canada on the CSE.
Looking for Cannabis Stocks?
Read our report to find market data, important news and stocks to watch!
Give me my free report!
The event included presentations from companies such as Quinsam Capital (CSE:QCA), QuadronCorp (CSE:QCC), and a presentation showcasing an event about upcoming public companies like Ascent Industries, a venture holding licenses to grow cannabis in Canada and the states of Nevada and Oregon.
The CSE was able to share to investors the growth some of its listed cannabis stocks have done such as MPX Bioceutical (CSE:MPX), CannaRoyalty (CSE:CRZ), Beleave (CSE:BE), TerrAscend (CSE:TER) and Liberty Health Sciences (CSE:LHS).
Miller told INN thanks to the positive outlook the US political landscape currently holds for cannabis–despite the drug remaining illegal at a federal level–has impacted the volume of listings on the CSE.
“It seems that the government is addressing the issue and they realize this is not going to be going away and quite frankly there’s a lot of revenue to be made from it and a lot of job opportunities and most importantly quality of life and health and wellness,” he said.
Outlook on US focused CSE listed companies Continue Reading